TAG:
COVID-19
COVID-19 is a disease whose name derives from “coronavirus disease 2019.” It is caused by an infection from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is often referred to more simply as COVID.
COVID-19 primarily affects the respiratory system. It has a 0.66% fatality rate, with those at an increased age, with a high body mass index, or with a history of lung or heart diseases being at a higher risk. In 80% of cases, it produces only mild symptoms.
However, in severe cases, it can cause critical illness, potentially leading to respiratory failure, septic shock, and multiple organ dysfunction syndrome.
A longer-term, but less understood, condition is called “long COVID,” which can result in post-infection conditions, including fatigue, heart problems, neurological concerns, and digestive issues.
The virus that causes COVID-19 is highly infectious, which led to a pandemic that was officially declared by the World Health Organization (WHO) on March 11, 2020. While the end of the pandemic was not officially announced by the WHO, many leading experts pinpointed its conclusion as occurring in the late spring or early summer of 2022.
COVID-19 had a profound impact on clinical laboratories, with a huge demand for SARS-CoV-2 testing occurring throughout the world, stimulated by government subsidies.
The COVID-19 pandemic resulted in lockdowns, masking, social distancing, and several other infection prevention measures to attempt to slow the spread of SARS-CoV-2. It also disrupted social, business, and educational activities throughout the world.
Several vaccines were developed in late 2020 and early 2021 to prevent the spread of COVID-19. While initially effective, such vaccination shows waning effectiveness over time, requiring booster shots. The vaccines were developed quickly—in less than a year—and are notable for being the first time that mRNA vaccine technology was ever authorized and approved for general use by healthcare regulators.
While the term “COVID-19” technically refers to the disease caused by SARS-CoV-2, the term is often misused to describe the virus. “COVID-19 testing”, for example, was often used to describe what would correctly have been referred to as SARS-CoV-2 testing, as the presence of the SARS-CoV-2 infection does not always cause COVID-19. “Asymptomatic COVID-19” is another misuse of the term, as COVID-19 is a disease that will produce some form of symptoms.
The nuances of the difference between SARS-CoV-2 and COVID-19 have generally been lost on the public, the media, and government officials, resulting in the two terms being used interchangeably.
Whistleblowers Disclose Issues in California’s COVID Lab
SUMMARY: Whistleblowers at the State of California’s brand-new COVID-19 Valencia Branch Laboratory are telling reporters about staff sleeping on the job, unlicensed staff handling specimens, and other significant issues. Given the reports of several news outlets, one relevant ques…
What’s Ahead for Labs? It’ll Be Quite Different
CEO SUMMARY: In many ways, the nation’s clinical laboratories performed magnificently in response to the SARS-CoV-2 outbreak last winter. But that magnificent performance has taken its toll on the infrastructure and personnel within these labs. The Dark Report…
SARS-CoV-2 Variant Sequencing Creates New Opportunities for Labs
This is an excerpt of a 2,964-word article in the February 8, 2021 issue of THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: Variants of the COVID-19 virus are appearing across the world. Recent data show the same variants wil…
Variant Sequencing of SARS-CoV-2 Creates Opportunities for Labs
CEO SUMMARY: Variants of the COVID-19 virus are appearing across the world. Recent data show the same variants will infect people in several different countries. Here in the United States, interest is growing in having clinical laboratories sequence specimens from patients who test pos…
Top 10 2020 Lab Stories Are about More than Just COVID-19
This is an excerpt of a 3,689-word article in the December 28, 2020 issue of THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: There are several surprises in The Dark R…
Medicare COVID Test Coding May Become a ‘Logistical Nightmare’
STARTING JAN. 1, 2021, clinical laboratories performing COVID-19 tests using high-throughput systems for Medicare patients must comply with a complex new coding rule when submitting claims for these tests. The federal Centers for Med…
CMS Publishes Proposed 2021 Medicare Physician Fee Schedule
MEDICARE’S PROPOSED PHYSICIAN FEE SCHEDULE (PFS) rule was announced on Aug. 4, 2020. The rule had one positive development for clinical laboratories and hospital laboratory outreach programs and a negative development for anatomic pathologists. Clinical laboratories and hospital outreach lab…
CURRENT ISSUE
Volume XXXI, No. 5 – April 8, 2024
The fragmentation of consumer markets is reflected in clinical lab services, and The Dark Report examines this trend and how it will impact labs in the coming years. Also, The Dark Report notes that the FDA has issued a controversial memo to reclassify many high-risk IVD assays.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.